Daniel Batlle

  • 7716 Citations
1978 …2023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Daniel Batlle MD is the Earle, del Greco, Levin Professor of Medicine at Northwestern University. He has been a Professor of Medicine at Northwestern and past Division Chief for 18 years . His clinical and research interests include acid-base disturbances, electrolyte disorders, hypertension, and diabetic nephropathy. Bench research currently involves the study of the renin angiotensin system and enzymes that degrade angiotensin 2 such as ACE2 and its potential therapeutic use.

Certifications and Licenses

Internal Medicine
Nephrology

Training Experience

1976Internship, Saint John Hospital and Medical Center, Detroit, Michigan
1977Residency, Wayne State University
1979Fellowship, Univ. of Illinois Hospital

Education/Academic qualification

MD, University of Barcelona

… → 1973

Research interests

  • Hypertension
  • Kidney
  • Nephrology

Fingerprint Dive into the research topics where Daniel Batlle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles
Kidney Medicine & Life Sciences
Renal Tubular Acidosis Medicine & Life Sciences
Angiotensin II Medicine & Life Sciences
Diabetic Nephropathies Medicine & Life Sciences
Acidosis Medicine & Life Sciences
Chronic Renal Insufficiency Medicine & Life Sciences
Potassium Medicine & Life Sciences
Hypertension Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2004 2023

MicroRNAs
Homeostasis
Corneal Epithelium
HDL Lipoproteins
Nanoparticles
Renin-Angiotensin System
Renin
Diabetes Complications
Type 1 Diabetes Mellitus
Albuminuria
Telecommunications
Allopurinol
Multicenter Studies
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
Clinical Trials

Research Output 1978 2019

Angiotensin-(1-7) for diabetic kidney disease: better than an angiotensin-converting enzyme inhibitor alone?

Marquez, A. & Batlle, D., Oct 1 2019, In : Kidney international. 96, 4, p. 815-817 3 p.

Research output: Contribution to journalComment/debate

Lisinopril
Diabetic Nephropathies
Angiotensin-Converting Enzyme Inhibitors
Peptides
angiotensin I (1-7)

Proximal renal tubular acidosis with and without fanconi syndrome

Kashoor, I. & Batlle, D., Sep 2019, In : Kidney Research and Clinical Practice. 38, 3, p. 267-281 15 p.

Research output: Contribution to journalReview article

Open Access
Fanconi Syndrome
Renal Tubular Acidosis
Acidosis
Bicarbonates
Sodium-Phosphate Cotransporter Proteins

Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus

For the Diabetes Control, Complications Trial (DCCT)/Epidemiology of Diabetes Interventions, Complications (EDIC) Study, Oct 1 2019, In : Physiological reports. 7, 19, e14242.

Research output: Contribution to journalArticle

Open Access
Angiotensinogen
Type 1 Diabetes Mellitus
Chronic Renal Insufficiency
Diabetes Complications
Kidney
1 Citation (Scopus)

Urinary Renin in Patients and Mice With Diabetic Kidney Disease

Tang, J., Wysocki, J., Ye, M., Vallés, P. G., Rein, J., Shirazi, M., Bader, M., Gomez, R. A., Sequeira-Lopez, M-L. S., Afkarian, M. & Batlle, D., Jul 2019, In : Hypertension (Dallas, Tex. : 1979). 74, 1, p. 83-94 12 p.

Research output: Contribution to journalArticle

Diabetic Nephropathies
Renin
Experimental Diabetes Mellitus
Diabetes Mellitus
Streptozocin

Apelinergic system in the kidney: implications for diabetic kidney disease

Müller, T., Kalea, A. Z., Marquez, A., Hsieh, I., Haque, S., Ye, M., Wysocki, J., Bader, M. & Batlle, D., Dec 1 2018, In : Physiological reports. 6, 23, e13939.

Research output: Contribution to journalArticle

Podocytes
Diabetic Nephropathies
Kidney
Glucose
Angiotensin II